Cathie's Ark Logo
10x Genomics Inc Logo

Combined Holdings of 10x Genomics (TXG) - Updated Daily

Single Cell GenomicsCell AnalyticsLab EquipmentLab EquipmentSpatial GenomicsWorkflow Automation
Date
Direction
Shares
Fund Weight
Fund
March 2, 2023
SELL121.318k0.0761%ARKK
March 1, 2023
SELL9.210k0.0058%ARKK
February 22, 2023
SELL72.892k0.0487%ARKK
August 26, 2022
BUY16.608k0.021%ARKG
August 25, 2022
BUY6.050k0.0081%ARKG

Key Statistics

⚖️Weighting🧢Market Cap
1.46%$5.85b
🏋️‍♀️Weight Rank Across All Funds🌏Country
21🇺🇸United States
💳ARK Estimated Cost Average🎫ARK Ownership Percent
$156.58 - ARKG$153.19 - ARKK
3.8%
Description
10x Genomics is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness.
Website
www.10xgenomics.com

Other ETFs That Hold TXG

Ticker
NameWeight
GNOMGlobal X Genomics & Biotechnology ETF7.87%
ARKGARK Genomic Revolution ETF2.24%
ARKKARK Innovation ETF1.95%
GDXVanEck Gold Miners ETF1.81%
IBBiShares Biotechnology ETF0.27%

Research Notes and Commentary for TXG

January 29, 2021

Ark Trades and Storylines

Trading Floor
10x is a workflow company that sells their system to the next-generation therapy companies like CRSP, FATE, CLLS and a host of other companies in...